U.S. Opioid Crackdown Hampers Some Patients’ Access to Psychiatric Drugs

December 12, 2022

(Reuters) – Five independent pharmacists in five different U.S. states told Reuters that in recent months they were notified by the wholesalers that they would be cut off from the distribution of all controlled substances after filling prescriptions for psychiatric drugs such as the stimulant Adderall – used to treat attention deficit hyperactivity disorder (ADHD) – and anti-anxiety drug Xanax. The pharmacists spoke on condition of anonymity for fear of harming their businesses. (Read More)